The New Apolipoprotein A-I Variant Leu174 → Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal Polypeptide-Reference-Cited by-同舟云学术

The New Apolipoprotein A-I Variant Leu174 → Ser Causes Hereditary Cardiac Amyloidosis, and the Amyloid Fibrils Are Constituted by the 93-Residue N-Terminal Polypeptide

Published:1999-09 Issue:3 Volume:155 Page:695-702
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Obici Laura,Bellotti Vittorio,Mangione Palma,Stoppini Monica,Arbustini Eloisa,Verga Laura,Zorzoli Irene,Anesi Ernesto,Zanotti Giuseppe,Campana Carlo,Viganò Mario,Merlini Giampaolo

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference23 articles.

1. Apolipoprotein A-I induced amyloidosis;Genschel;FEBS Lett,1998

2. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques;Westermark;Am J Pathol,1995

3. Pulmonary vascular amyloidosis in aged dogs: a new form of spontaneously occurring amyloidosis derived from apolipoprotein AI;Johnson;Am J Pathol,1992

4. Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation;Amarzguioui;Biochem Biophys Res Commun,1998

5. The plasma lecithins: cholesterol acyltransferase reaction;Glomset;J Lipid Res,1968

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms;FEBS Letters;2024-03-26

2. Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant;Amyloid;2023-03-29

3. Amyloidosis and Other Protein Deposition Diseases;Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics;2023

4. Current approaches to the diagnosis and management of amyloidosis;Internal Medicine Journal;2022-12

5. The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre;Amyloid;2022-05-03